XML 47 R39.htm IDEA: XBRL DOCUMENT v3.25.1
Agreement and Plan of Merger - Summary of Assumptions Used to Determine Fair Value of the Assumed Warrants (Details) - Peak Bio
Nov. 14, 2024
yr
Stock price  
Agreement And Plan Of Merger [Line Items]  
Warrants outstanding, measurement input 2.23
Expected dividend yield  
Agreement And Plan Of Merger [Line Items]  
Warrants outstanding, measurement input 0
Peak Bio Assumed Warrants November 2022 | Stock price  
Agreement And Plan Of Merger [Line Items]  
Warrants outstanding, measurement input 2.23
Peak Bio Assumed Warrants November 2022 | Exercise price  
Agreement And Plan Of Merger [Line Items]  
Warrants outstanding, measurement input 39.18
Peak Bio Assumed Warrants November 2022 | Expected term (in years)  
Agreement And Plan Of Merger [Line Items]  
Warrants outstanding, measurement input 3
Peak Bio Assumed Warrants November 2022 | Volatility  
Agreement And Plan Of Merger [Line Items]  
Warrants outstanding, measurement input 86.4
Peak Bio Assumed Warrants November 2022 | Risk-free rate  
Agreement And Plan Of Merger [Line Items]  
Warrants outstanding, measurement input 4.3
Peak Bio Assumed Warrants April 2023 | Stock price  
Agreement And Plan Of Merger [Line Items]  
Warrants outstanding, measurement input 2.23
Peak Bio Assumed Warrants April 2023 | Exercise price  
Agreement And Plan Of Merger [Line Items]  
Warrants outstanding, measurement input 2.04
Peak Bio Assumed Warrants April 2023 | Expected term (in years)  
Agreement And Plan Of Merger [Line Items]  
Warrants outstanding, measurement input 3.5
Peak Bio Assumed Warrants April 2023 | Volatility  
Agreement And Plan Of Merger [Line Items]  
Warrants outstanding, measurement input 84.1
Peak Bio Assumed Warrants April 2023 | Risk-free rate  
Agreement And Plan Of Merger [Line Items]  
Warrants outstanding, measurement input 4.3